Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Foundation Updates
Donate Now

Foundation Updates

Read expert commentary, insights and general announcements on how the Foundation is paving the way for Parkinson's research.
  • Health care professional and person in a room

    “How Do I Know it’s a ‘Good’ Trial?” Questions to Ask Before Joining a Parkinson’s Study

    Important questions to ask if you are interested in joining a Parkinson’s study.
    Learn more Save for later
  • brain scanner

    What We Fund: Seeing, Measuring and Targeting Parkinson’s Disease

    The Michael J. Fox Foundation awarded $101 million in December 2025 and January 2026 to advance research toward better Parkinson’s disease treatments. Learn more.
    Learn more Save for later
  • Timothy Greenamyre, MD, PhD

    How Artificial Intelligence Helps Power Parkinson’s Research

    Artificial intelligence helps drive Parkinson’s research at The Michael J. Fox Foundation in unique ways. Learn more.
    Learn more Save for later
  • Celia and Pat sitting together in a booth.

    Making the Most of Generosity: Why Pat & Celia Gave via an IRA

    Pat and Celia wanted to give as much as possible to Parkinson’s research. Donating to The Michael J. Fox Foundation via an IRA made their wish a reality.
    Learn more Save for later
  • Krista (left) and John (right) Karpowich.

    It’s More than a Gift, It’s a Lasting Legacy

    John and Krista’s journey to help end Parkinson’s disease by supporting The Michael J. Fox Foundation. Learn more.
    Learn more Save for later
  • Article header in The Free Press, featuring Michael J. Fox.

    Michael J. Fox Reflects on Parkinson’s, Advocacy, and a Return to Acting in "The Free Press”

    Learn more Save for later
  • FDA Building 21 stands behind the sign at the campus's main entrance and houses the Center for Drug Evaluation and Research. The FDA campus is located at 10903 New Hampshire Ave., Silver Spring, MD 20993.

    Second FDA Response Letter Issued for ND0612 Therapy

    The Michael J. Fox Foundation offers updates on the FDA review of ND0612, a potential new Parkinson’s therapy designed to help manage motor symptoms.
    Learn more Save for later
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.